Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE009119 |
ID: | TCMBANKHE009119 |
植物拉丁名: |
|
功能与主治: | To clear heat and resolve toxin, suppress cough and interrupt malaria./Malaria, malign malaria, common cold, ardent fever, cough with profuse phlegm. |
药用植物名: | 土连翘 |
药用部位: | bark |
TCM_ID_id: | 7139 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000648 | morolic acid | morolicacid | C30H48O3 | 456.7 g/mol | CC1(CCC2(CCC3(C(C2=C1)CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C)C(=O)O)C |
| TCMBANKIN002592 | rubiadin primeveroside | C26H28O13 | 548.5 g/mol | CC1=C(C=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)OC4C(C(C(C(O4)COC5C(C(C(CO5)O)O)O)O)O)O | |
| TCMBANKIN016280 | 5-o-methylembelin | C18H28O4 | 308.4 g/mol | CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)OC)O | |
| TCMBANKIN020176 | anthragallol | C14H8O5 | 256.21 g/mol | C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)O)O | |
| TCMBANKIN024138 | Nordamnacanthal | 2-Anthracenecarboxaldehyde, 9,10-dihydro-1,3-dihydroxy-9,10-dioxo-; AIDS098139; AIDS-098139; 1,3-dihydroxy-9,10-dioxo-anthracene-2-carbaldehyde; nordamnacanthal; 1,3-dihydroxy-9,10-dioxo-2-anthracenecarboxaldehyde; nordamnacanthal ; 1,3-dihydroxy-9,10-diketo-anthracene-2-carbaldehyde; CCRIS 6442; 3736-59-2; 1,3-dihydroxy-9,10-dioxoanthracene-2-carbaldehyde | C15H8O5 | 268.22 | C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)C=O)O |
| TCMBANKIN026617 | rubiadin | W1217; RTR-032746; AC1L3XTD; 1, 3-dihydroxy-2-methyl anthraquinone; NP-012908; UNII-CY0UH3X06R; KB-216455; AK111254; KSC937O7B; 1,3-dihydroxy-2-methyl-anthracene-9,10-dione; SCHEMBL1426928; LS-188104; FT-0687288; CCRIS 4533; 117-02-2; 1,3-dihydroxy-2-methylanthraquinone; AIDS-098142; MolPort-003-824-764; AC1Q6JWT; 9,10-Anthracenedione, 1,3-dihydroxy-2-methyl-; CY0UH3X06R; AJ-48018; A1-06841; Rubiadin, analytical standard; ST24036800; 4CN-2427; Rubiadin; Rubiadine; 1,3-dihydroxy-2-methyl-9,10-anthraquinone; ZINC4098705; 1,3-dihydroxy-2-methylanthracene-9,10-dione; DB-025540; NCGC00386035-01!1,3-dihydroxy-2-methylanthracene-9,10-dione; CTK8D7770; CHEBI:69533; DTXSID90151651; Q-100965; AKOS015914028; AIDS098142; MCULE-1867080462; I14-45158; C10402; CHEMBL251251 | C15H10O4 | 254.24 g/mol | CC1=C(C=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O |
| TCMBANKIN031228 | 6-methylcodeine | ||||
| TCMBANKIN031265 | damnacanthal | damnacanthal | C16H10O5 | 282.25 g/mol | COC1=C2C(=CC(=C1C=O)O)C(=O)C3=CC=CC=C3C2=O |
| TCMBANKIN032969 | damnacanthol | C16H12O5 | 284.26 g/mol | COC1=C2C(=CC(=C1CO)O)C(=O)C3=CC=CC=C3C2=O | |
| TCMBANKIN044375 | 18-nordehydroabietan-4alpha-ol | 18-nordehydroabietan-4α-ol | C19H28O | 0 | CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)O)C |
| TCMBANKIN048228 | 2'beta,13alpha,14beta-trisdeacetylaustrotaxine | 2'β,13α,14β-trisdeacetylaustrotaxine | C35H47NO10 | ||
| TCMBANKIN058273 | aesculin;esculin | Esculin hydrate, >=98%; SR-01000633930; CHEBI:73111; DTXSID60583344; Esculin hydrate; SMR001562115; A-D-glucopyranoside; Esculetin-6-; CHEMBL1718108; (-)-ESCULIN HYDRATE; AKOS025310104; Esculin sesquihydrate; SCHEMBL829959; Esculin monohydrate; 7-hydroxy-2-oxo-2H-chromen-6-yl beta-D-glucopyranoside--water (1/1); FT-0625710; C15H16O9.xH2O; Esculin sesquihydrate, p.a., 98%; C15H18O10; SR-01000633930-4; SC-21492; 340.2821 (anhydrous basis); MLS002695944; Esculin hydrate, analytical standard; Esculin hydrate, >=98.0% (HPLC); BG01647212; A-7671; AS-11688; 7-Hydroxy-2-oxo-2H-1-benzopyran-6-yl beta-D-glucopyranoside--water (1/1); MFCD00149492; MolPort-003-665-735; 66778-17-4; Esculin sesquihydrate, tested according to DAB;NINDS_000956; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-2-one; Spectrum3_000731; Esculoside; AIDS002655; DivK1c_000956; SPBio_000392; SMP1_000008; 7-hydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-1-benzopyran-2-one hydrate; KBio2_003409; 7-hydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-chromenone; ZINC03860441; Spectrum4_001923; 2H-1-Benzopyran-2-one, 6-(.beta.-D-glucopyranosyloxy)-7-hydroxy-; Crataegin; Polychrom; 6,7-Dihydrocoumarin-6-glucoside; HMS3373P07; KBio3_001502; KBio2_005977; Esculetin 6-b-D-glucoside; SDCCGMLS-0066653.P001; Bicolorin; SPECTRUM1500901; Escosyl; KBio2_000841; Spectrum2_000576; 531-75-9; BCBcMAP01_000202; AIDS-002655; Polychrome; IDI1_000956; Esculetin 6-O-glucoside; 81320_FLUKA; Polychrome solution; KBioGR_002266; Enallachrome; Esculin; Vitamin C2; 6-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-7-oxidanyl-chromen-2-one hydrate; KBioSS_000841; Esculine; Spectrum_000361; KBio1_000956; A829428; BSPBio_002282; Spectrum5_000845; C09264; 6-(.beta.-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-coumarin; STOCK1N-51823; SR-01000633930-1; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-2-one | C15H16O9 | 340.28 g/mol | C1=CC(=O)OC2=CC(=C(C=C21)OC3C(C(C(C(O3)CO)O)O)O)O |
| TCMBANKIN058387 | lucidin | lucidin;Henine;1,3-dihydroxy-2-methylol-9,10-anthraquinone; Lucidin (quinone); 9,10-Anthracenedione, 1,3-dihydroxy-2-(hydroxymethyl)-; C10369; 1,3-Dihydroxy-2-hydroxymethylanthraquinoline; ANTHRAQUINONE, 1,3-DIHYDROXY-2-HYDROXYMETHYL-; NSC30546; 4-08-00-03576 (Beilstein Handbook Reference); 478-08-0; HSDB 7146; CCRIS 1642; Lucidin; 1,3-dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione; 1,3-Dihydroxy-2-(hydroxymethyl)anthraquinone; NSC 30546; 9,10-Anthracenedione, 1,3-dihydroxy-2-(hydroxymethyl)- (9CI); BRN 1888954; Anthraquinone, 1,3-dihydroxy-2-(hydroxymethyl)-; WLN: L C666 BV IVJ DQ E1Q FQ | C15H10O5 | 270.24 g/mol | C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)CO)O |
| TCMBANKIN059743 | Morindon | C15H10O5 | 270.24 g/mol | CC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C=CC(=C3O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab